Related Experiment Videos
Genomic instability and breast cancer
S Colleu-Durel1, N Guitton, K Nourgalieva
1Unite de Radiobiologie, UPRES EA No. 2231, Centre Eugene Marquis, F-35062 Rennes, France.
Oncology Reports
|August 10, 2001
Summary
Patients with sporadic breast cancer exhibit higher baseline DNA damage, indicating genomic instability. This instability is further exacerbated by in vitro irradiation, suggesting a heightened sensitivity in cancer cells.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Genomic instability is a key hallmark of cancer.
- A link between genomic instability and cancer predisposition is established in genetic syndromes.
- Sporadic breast cancer, lacking known genetic predispositions, requires investigation into its genomic stability.
Purpose of the Study:
- To evaluate genomic instability in lymphocytes of sporadic breast cancer patients.
- To compare DNA damage levels in cancer patients versus healthy controls.
- To assess the impact of in vitro irradiation on DNA damage in patient lymphocytes.
Main Methods:
- Utilized the alkaline comet assay (single-cell gel electrophoresis) on lymphocytes from 19 sporadic breast cancer patients and controls.
- Assayed DNA damage (single-strand breaks, alkali-labile sites) in G(0) cells.
- Exposed cells in vitro to varying doses of irradiation (50 cGy to 5 Gy).
Main Results:
- Breast cancer patients displayed significantly higher baseline levels of DNA damage compared to controls.
- In vitro irradiation increased DNA damage markers (tail moment, score, DNA in tail) in both groups, but more pronouncedly in patients.
- Lymphocyte DNA in cancer patients showed greater damage, irrespective of irradiation status.
Conclusions:
- Baseline DNA damage in lymphocytes suggests inherent genomic instability in sporadic breast cancer.
- This genomic instability appears to be amplified following in vitro irradiation.
- The findings support the hypothesis that genomic instability contributes to sporadic breast cancer development.